Harry Bartelink
Dept of Radiation Oncology, Netherlands Cancer Institute, Netherlands
Harry Bartelink
Academic positions:
- Chairman of the Radiotherapy Division, The Netherlands Cancer Institute in Amsterdam
- Professor in Clinical Experimental Radiotherapy, University of Amsterdam
Any industry positions (last five years):
None declared
Research interests:
Dr Bartelink's main scientific activities include measurements of growth and regression rate of human tumours, irradiated with photons or fast neutrons; interaction of radiotherapy and chemotherapy in patients with lung, breast and head and neck cancer; predictive assays indicating possible adaptation of fractionation schedules; high dose-high precision radiotherapy; image processing and quality assurance. Recently his attention has been focused on the prediction of treatment outcome with micro-arrays in breast cancer patients.
Any other information:
Dr Bartelink currently holds various honorary positions:
- Honorary fellow of the American College of Radiology
- ESTRO Breur Medallist
- GH Fletcher Award
- Member of the Board of several European organizations (EORTC, EUSOMA, ECC, CTAAC)
- Past President of ESTRO
- President-elect of Federation of European Cancer Societies (FECS)
He is a member of several editorial boards: International Journal of Radiation, Oncology, Biology and Physics, Radiotherapy & Oncology, European Journal of Cancer, The Breast, Journal of Oncology, The Cancer Journal of Scientific American, The Oncologist.
Any competing interests declared are displayed with individual evaluations.
Section Head: Oncology > Breast Diseases: Benign & Malignant (since 16 November 2005)
Harry Bartelink is a Section Head for Breast Diseases: Benign & Malignant, part of the ONCOLOGY Faculty. The role of a Section Head is to work with their Co-Section Head(s) to divide the Section (sub-specialty area) into its component areas of research, nominate leaders in those areas as Faculty Members, and offer ongoing oversight of the content within their Section. They are not asked to evaluate articles, although we do, of course, welcome them.Links
http://www.nki.nl/Research/Faculty+and+Research/Divisions/Radiotherapy/Bartelink.htm
